CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) of $6.93 million as of 2013-06-29, per its 10-Q filed 2013-07-31.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesFairValueDisclosure · last filed 2013-07-31
- 2013-06-29: Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) $6.93M.
- 2013-03-30: Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) $6.85M.
- 2012-12-29: Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) $6.78M.
- 2012-09-29: Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) $6.35M.
| Period end | Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) |
|---|---|
| 2013-06-29 | $6.93M 10-Q · filed 2013-07-31 |
| 2013-03-30 | $6.85M 10-Q · filed 2013-05-08 |
| 2012-12-29 | $6.78M 10-Q · filed 2013-07-31 |
| 2012-09-29 | $6.35M 10-Q · filed 2012-11-01 |
| 2012-06-30 | $6.62M 10-Q · filed 2012-08-07 |
| 2012-03-31 | $6.14M 10-Q · filed 2012-05-04 |
| 2011-12-31 | $16.41M 10-K · filed 2013-02-27 |
| 2011-09-24 | $17.26M 10-Q · filed 2011-11-02 |
| 2011-06-25 | $23.02M 10-Q · filed 2011-08-03 |
| 2010-12-25 | $21.21M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |